Klaus Fink

8.8k total citations · 3 hit papers
82 papers, 7.4k citations indexed

About

Klaus Fink is a scholar working on Molecular Biology, Cellular and Molecular Neuroscience and Physiology. According to data from OpenAlex, Klaus Fink has authored 82 papers receiving a total of 7.4k indexed citations (citations by other indexed papers that have themselves been cited), including 61 papers in Molecular Biology, 49 papers in Cellular and Molecular Neuroscience and 8 papers in Physiology. Recurrent topics in Klaus Fink's work include Neuroscience and Neuropharmacology Research (43 papers), Ion channel regulation and function (30 papers) and Neurotransmitter Receptor Influence on Behavior (21 papers). Klaus Fink is often cited by papers focused on Neuroscience and Neuropharmacology Research (43 papers), Ion channel regulation and function (30 papers) and Neurotransmitter Receptor Influence on Behavior (21 papers). Klaus Fink collaborates with scholars based in Germany, United States and Czechia. Klaus Fink's co-authors include Manfred Göthert, M. G�thert, Eberhard Schlicker, Junying Yuan, Matthias Endres, Robert M. Friedlander, Michael A. Moskowitz, Hideaki Hara, Valeria Gagliardini and Jinmin Zhu and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Circulation and Journal of Clinical Investigation.

In The Last Decade

Klaus Fink

81 papers receiving 7.1k citations

Hit Papers

Minocycline inhibits caspase-1 and caspase-3 expression a... 1997 2026 2006 2016 2000 1998 1997 250 500 750
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Minocycline inhibits caspase-1 and caspase-3 expression and delays mortality in a transgenic mouse model of Huntington disease
    2000 869 citations Klaus Fink, Robert M. Friedlander et al. profile →
  2. Activation and Cleavage of Caspase-3 in Apoptosis Induced by Experimental Cerebral Ischemia
    1998 780 citations Shobu Namura, Jinmin Zhu et al. Journal of Neuroscience profile →
  3. Inhibition of interleukin 1β converting enzyme family proteases reduces ischemic and excitotoxic neuronal damage
    1997 704 citations Hideaki Hara, Robert M. Friedlander et al. Proceedings of the National Academy of Sciences profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Klaus Fink Germany 39 4.0k 2.8k 1.1k 1.0k 982 82 7.4k
Lucio Annunziato Italy 58 5.0k 1.3× 3.5k 1.3× 429 0.4× 886 0.8× 1.4k 1.4× 285 10.2k
Laura Facci Italy 46 2.7k 0.7× 2.1k 0.8× 826 0.8× 1.2k 1.1× 1.2k 1.3× 119 6.8k
Thomas Herdegen Germany 66 6.3k 1.6× 5.4k 1.9× 761 0.7× 1.4k 1.3× 2.3k 2.4× 186 12.9k
Robert O. Messing United States 58 5.2k 1.3× 4.9k 1.8× 438 0.4× 1.1k 1.1× 2.1k 2.1× 177 10.7k
Barbara Monti Italy 32 2.9k 0.7× 2.1k 0.7× 1.1k 1.0× 2.9k 2.8× 1.5k 1.5× 95 8.4k
U. Otten Switzerland 55 2.8k 0.7× 5.9k 2.1× 1.2k 1.1× 1.8k 1.7× 2.1k 2.2× 156 10.3k
Dandan Sun United States 51 3.4k 0.9× 2.4k 0.9× 484 0.4× 1.7k 1.6× 767 0.8× 189 7.3k
Mark P. Goldberg United States 49 3.6k 0.9× 4.0k 1.4× 331 0.3× 2.1k 2.0× 1.1k 1.1× 119 8.3k
Masabumi Minami Japan 57 3.5k 0.9× 4.3k 1.5× 1.3k 1.2× 1.6k 1.5× 2.6k 2.7× 248 9.5k
Maria P. Abbracchio Italy 61 5.5k 1.4× 3.6k 1.3× 1.1k 1.0× 2.7k 2.6× 1.6k 1.6× 233 14.8k

Countries citing papers authored by Klaus Fink

Since Specialization
Citations

This map shows the geographic impact of Klaus Fink's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Klaus Fink with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Klaus Fink more than expected).

Fields of papers citing papers by Klaus Fink

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Klaus Fink. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Klaus Fink. The network helps show where Klaus Fink may publish in the future.

Co-authorship network of co-authors of Klaus Fink

This figure shows the co-authorship network connecting the top 25 collaborators of Klaus Fink. A scholar is included among the top collaborators of Klaus Fink based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Klaus Fink. Klaus Fink is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Charntikov, Sergios, Natashia Swalve, Steven T. Pittenger, et al.. (2013). Iptakalim attenuates self-administration and acquired goal-tracking behavior controlled by nicotine. Neuropharmacology. 75. 138–144. 23 indexed citations
2.
3.
Baumgarten, Georg, Pascal Knuefermann, Hermann Wrigge, et al.. (2006). Role of Toll-like receptor 4 for the pathogenesis of acute lung injury in Gram-negative sepsis. European Journal of Anaesthesiology. 23(12). 1041–1048. 38 indexed citations
4.
Fink, Klaus, David Dooley, Wolfgang Meder, et al.. (2002). Inhibition of neuronal Ca2+ influx by gabapentin and pregabalin in the human neocortex. Neuropharmacology. 42(2). 229–236. 389 indexed citations
5.
Meder, Wolfgang, Klaus Fink, Josef Zentner, & Manfred Göthert. (1999). Calcium Channels Involved in K+- and Veratridine-Induced Increase of Cytosolic Calcium Concentration in Human Cerebral Cortical Synaptosomes. Journal of Pharmacology and Experimental Therapeutics. 290(3). 1126–1131. 28 indexed citations
6.
Namura, Shobu, Jinmin Zhu, Klaus Fink, et al.. (1998). Activation and Cleavage of Caspase-3 in Apoptosis Induced by Experimental Cerebral Ischemia. Journal of Neuroscience. 18(10). 3659–3668. 780 indexed citations breakdown →
7.
Fink, Klaus, Jinmin Zhu, Shobu Namura, et al.. (1998). Prolonged Therapeutic Window for Ischemic Brain Damage Caused by Delayed Caspase Activation. Journal of Cerebral Blood Flow & Metabolism. 18(10). 1071–1076. 179 indexed citations
8.
Kristof, Rudolf A., Hans Clusmann, Wolfgang Köehler, Klaus Fink, & J. Schramm. (1998). Treatment of accidental high dose intraventricular mezlocillin application by cerebrospinal fluid exchange. Journal of Neurology Neurosurgery & Psychiatry. 64(3). 379–381. 12 indexed citations
9.
Hara, Hideaki, Klaus Fink, Matthias Endres, et al.. (1997). Attenuation of Transient Focal Cerebral Ischemic Injury in Transgenic Mice Expressing a Mutant ICE Inhibitory Protein. Journal of Cerebral Blood Flow & Metabolism. 17(4). 370–375. 193 indexed citations
10.
Schlicker, Eberhard, Klaus Fink, Gerhard J. Molderings, et al.. (1997). Effects of selective h5-HT1B (SB-216641) and h5-HT1D (BRL-15572) receptor ligands on guinea-pig and human 5-HT auto- and heteroreceptors. Naunyn-Schmiedeberg s Archives of Pharmacology. 356(3). 321–327. 60 indexed citations
11.
Hara, Hideaki, Robert M. Friedlander, Valeria Gagliardini, et al.. (1997). Inhibition of interleukin 1β converting enzyme family proteases reduces ischemic and excitotoxic neuronal damage. Proceedings of the National Academy of Sciences. 94(5). 2007–2012. 704 indexed citations breakdown →
12.
Göthert, Manfred, Klaus Fink, Daniela Frölich, et al.. (1995). Presynaptic 5-HT auto- and heteroreceptors in the human central and peripheral nervous system. Behavioural Brain Research. 73(1-2). 89–92. 35 indexed citations
13.
Fink, Klaus, et al.. (1993). Modulation of N-methyl-d-aspartate (NMDA)-stimulated noradrenaline release in rat brain cortex by presynaptic ?2-adrenoceptors. Naunyn-Schmiedeberg s Archives of Pharmacology. 348(4). 372–8. 15 indexed citations
14.
Fink, Klaus, et al.. (1992). Inhibition of N-methyl-d-aspartate- and kainate-evoked noradrenaline release in human cerebral cortex slices by ethanol. Naunyn-Schmiedeberg s Archives of Pharmacology. 345(6). 700–703. 16 indexed citations
15.
16.
Fink, Klaus, et al.. (1990). Veratridine and other depolarizing agents counteract the inhibitory effect of Mg2+ ions on N-methyl-D-aspartate (NMDA)-induced noradrenaline release in vitro. Naunyn-Schmiedeberg s Archives of Pharmacology. 342(1). 53–60. 14 indexed citations
17.
Michel, Martin C., Eberhard Schlicker, Klaus Fink, et al.. (1990). Distinction of NPY receptors in vitro and in vivo. I. NPY-(18-36) discriminates NPY receptor subtypes in vitro. American Journal of Physiology-Endocrinology and Metabolism. 259(1). E131–E139. 34 indexed citations
18.
Schlicker, Eberhard, Klaus Fink, M. G�thert, et al.. (1989). The pharmacological properties of the presynaptic serotonin autoreceptor in the pig brain cortex conform to the 5-HT1D receptor subtype. Naunyn-Schmiedeberg s Archives of Pharmacology. 340(1). 45–51. 85 indexed citations
19.
Fink, Klaus, M. G�thert, G. J. Molderings, & Eberhard Schlicker. (1989). N-Methyl-d-aspartate (NMDA) receptor-mediated stimulation of noradrenaline release, but not release of other neurotransmitters, in the rat brain cortex: receptor location, characterization and desensitization. Naunyn-Schmiedeberg s Archives of Pharmacology. 339(5). 514–521. 84 indexed citations
20.
Molderings, Gerhard J., Klaus Fink, Eberhard Schlicker, & M. G�thert. (1987). Inhibition of noradrenaline release via presynaptic 5-HT1B receptors of the rat vena cava. Naunyn-Schmiedeberg s Archives of Pharmacology. 336(3). 245–50. 60 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Lucio Annunziato Breakdown of academic impact, for papers by Laura Facci Breakdown of academic impact, for papers by Thomas Herdegen Breakdown of academic impact, for papers by Robert O. Messing Breakdown of academic impact, for papers by Barbara Monti Breakdown of academic impact, for papers by U. Otten Breakdown of academic impact, for papers by Dandan Sun Breakdown of academic impact, for papers by Mark P. Goldberg Breakdown of academic impact, for papers by Masabumi Minami Breakdown of academic impact, for papers by Maria P. Abbracchio
Rankless by CCL
2026